Walleye Trading’s Psyence Biomedical Warrant PBMWW Stock Holding History
Bought
Maintained
Sold
Other funds holding PBMWW
HCI
PAMP
MI
CF
SCM
AC
LP
PC
Walleye Trading's PBMWW Position: Q1 2025 in Review
Walleye Trading sold out of Psyence Biomedical Warrant (PBMWW) in Q1 2025, closing a stake of 44,080 shares — an estimated $635 sold.
Walleye Trading first reported a position in PBMWW in Q1 2024 and held it in 4 quarters. The position peaked at $1.71K in Q1 2024. 23 funds tracked by Wall St. Rank hold PBMWW as of Q1 2025.
- Walleye Trading reported no remaining Psyence Biomedical Warrant position as of Q1 2025 after selling out during the quarter.
- Walleye Trading sold 44,080 Psyence Biomedical Warrant shares in Q1 2025, an estimated $635.
- Walleye Trading first reported a position in Psyence Biomedical Warrant in Q1 2024 and held it in 4 quarters.
- Walleye Trading's Psyence Biomedical Warrant position peaked at $1.71K in Q1 2024.
- 23 funds tracked by Wall St. Rank held Psyence Biomedical Warrant as of Q1 2025.
Based on Walleye Trading's 13F filing for Q1 2025, filed 14 May 2025.